Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Zhonglian Pharmaceutical is a comprehensive pharmaceutical manufacturer based in Shenzhen, China, specializing in the research, development, and production of chemical drugs and traditional Chinese medicines. Founded in 1985, the company has established a significant market presence in therapeutic areas including cardiovascular health, respiratory diseases, and gastrointestinal disorders. In 2014, the company was acquired by China Resources Sanjiu Medical & Pharmaceutical (CR Sanjiu), one of China's largest state-owned pharmaceutical groups, to serve as a core manufacturing hub for chemical generics. The company operates modern, GMP-certified facilities and is recognized for its high-quality sustained-release formulations and essential medicines. Today, it continues to support the broader CR Sanjiu portfolio while maintaining its own established brand of pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Zhonglian Pharmaceutical.